An app to help glaucoma patients remember their eye drop schedule
Assessing the Effects of an In-office, Language-concordant App on Eye Drop Recall in Patients With Multi-drop Regimens
NA · University of California, San Francisco · NCT06045390
This study is testing whether an app can help glaucoma patients remember to take their eye drops on schedule.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco (other) |
| Locations | 1 site (San Francisco, California) |
| Trial ID | NCT06045390 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to determine if an instructional app can enhance the recall of eye drop regimens among glaucoma patients using multiple drops. Participants will be randomly assigned to either use the app, which provides narrated instructions and quizzes, or not use the app. The app features a pictorial representation of the drops, a quiz to test understanding, and a graphical printout of the regimen. The effectiveness of the app will be evaluated one month after the intervention by assessing participants' ability to recall their eye drop regimen.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with primary open-angle glaucoma who are prescribed at least two eye drops.
Not a fit: Patients who have concurrent eye conditions requiring additional eye drops or those unable to self-administer eye drops may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve adherence to eye drop regimens in glaucoma patients, potentially leading to better disease management.
How similar studies have performed: While similar approaches using technology for medication adherence have shown promise, this specific application for glaucoma patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with a diagnosis of glaucoma (any type) * drop regimen of at least 2 pressure-lowering drops * languages supported at this time: English, Spanish, Cantonese Exclusion Criteria: * concurrent eye conditions necessitating additional eye drops * inability to self-administer eye drops * inability to engage with app (either visual or other barrier)
Where this trial is running
San Francisco, California
- San Francisco General Hospital — San Francisco, California, United States (RECRUITING)
Study contacts
- Principal investigator: Frank Brodie, MD — UCSF, Department of Ophthalmology
- Study coordinator: Sachin Patel, MD, PhD
- Email: sachin.patel@ucsf.edu
- Phone: 415-353-2800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Glaucoma